ReviewFrontiers in oncology2022
Chimeric antigen receptor T-cell therapy for T-ALL and AML.
Wenwen Wei et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
18 papers cite it
this paperpooled itcites it
ReviewFrontiers in oncology2022
Wenwen Wei et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.